STATESVILLE, N.C., Aug. 11, 2021 /PRNewswire/ -- Kewaunee Scientific
Corporation (NASDAQ: KEQU), a recognized global leader in the
design, manufacture, and installation of laboratory, healthcare,
and technical furniture products, is proud to announce its
partnership with NuAire, a global leader in the manufacturing and
distribution of equipment for a diverse range of laboratory and
pharmacy environments. This partnership expands Kewaunee's
current product offering, providing Kewaunee's customers access to
NuAire's portfolio of products, while offering NuAire access to
Kewaunee's market leading global distribution channels.
"The global market for products that Kewaunee and NuAire offer
continues to grow", says Thomas D. Hull
III, President & Chief Executive Officer, Kewaunee
Scientific Corporation. "The biosafety cabinet market is
growing rapidly due to increased investment in research and
development activities requiring the safety and performance of
these products. Providing Kewaunee's customers access to
NuAire's portfolio enhances our value proposition as customers are
looking for partners with the capability to provide turn-key
solutions when building a new laboratory or modernizing an existing
facility. The partnership is a win-win for both
organizations, leveraging the strengths of two market leaders."
About NuAire
Founded in 1971, NuAire is universally recognized as one of the
world's leading providers of reliable equipment for the most
demanding environments, including Biosafety Cabinets, CO2
Incubators, Laminar Air Flow Workstations, Containment Ventilated
Enclosures, Ultralow Temperature Freezers, General Purpose
Centrifuges, Animal Transfer Stations, Animal Refuse Workstations,
Restricted Access Barrier Systems, Polypropylene Fume Hoods,
Polypropylene Casework, and a variety of complementary products and
systems. NuAire's website is located at
https://www.nuaire.com/.
About Kewaunee Scientific
Founded in 1906, Kewaunee Scientific Corporation is a recognized
global leader in the design, manufacture, and installation of
laboratory, healthcare, and technical furniture products. The
Company's products include steel, wood, and laminate casework, fume
hoods, adaptable modular systems, moveable workstations,
stand-alone benches, biological safety cabinets, and epoxy resin
worksurfaces and sinks.
The Company's corporate headquarters are located in Statesville, North Carolina. Direct sales
offices are located in the United
States, India, Saudi Arabia, and Singapore. Three manufacturing facilities are
located in Statesville serving the
domestic and international markets, and one manufacturing facility
is located in Bangalore, India
serving the local and Asian markets. Kewaunee Scientific's website
is located at https://www.kewaunee.com.
This press release contains statements that the Company
believes to be "forward-looking statements" within the meaning of
the Private Securities Litigation Reform Act of 1995. All
statements other than statements of historical fact included in
this press release, including statements regarding the Company's
future financial condition, results of operations, business
operations and business prospects, are forward-looking statements.
Words such as "anticipate," "estimate," "expect," "project,"
"intend," "plan," "predict," "believe" and similar words,
expressions and variations of these words and expressions are
intended to identify forward-looking statements. Such
forward-looking statements are subject to known and unknown risks,
uncertainties, assumptions, and other important factors that could
significantly impact results or achievements expressed or implied
by such forward-looking statements. Such factors, risks,
uncertainties and assumptions include, but are not limited to:
competitive and general economic conditions and the ongoing impact
of the COVID-19 pandemic, including disruptions from government
mandates, both domestically and internationally; changes in
customer demands; technological changes in our operations or in our
industry; dependence on customers' required delivery schedules;
risks related to fluctuations in the Company's operating results
from quarter to quarter; risks related to international operations,
including foreign currency fluctuations; changes in the legal and
regulatory environment; changes in raw materials and commodity
costs; and acts of terrorism, war, governmental action, natural
disasters and other Force Majeure events. The cautionary statements
made pursuant to the Reform Act herein and elsewhere by us should
not be construed as exhaustive. We cannot always predict what
factors would cause actual results to differ materially from those
indicated by the forward-looking statements. Over time, our actual
results, performance, or achievements will likely differ from the
anticipated results, performance or achievements that are expressed
or implied by our forward-looking statements, and such difference
might be significant and harmful to our stockholders' interest.
Many important factors that could cause such a difference are
described under the caption "Risk Factors," in Item 1A of our
Annual Report on Form 10-K for the fiscal year ended April 30, 2020, which you should review
carefully, and in our subsequent quarterly reports on Form 10-Q and
current reports on Form 8-K. These reports are available on our
investor relations website at www.kewaunee.com and on the SEC
website at www.sec.gov. These forward-looking statements speak only
as of the date of this document. The Company assumes no obligation,
and expressly disclaims any obligation, to update any
forward-looking statements, whether as a result of new information,
future events or otherwise.
Contact:
Donald T. Gardner III
704/871-3274
View original content to download
multimedia:https://www.prnewswire.com/news-releases/kewaunee-scientific-corporation-announces-distribution-partnership-with-nuaire-301353666.html
SOURCE Kewaunee Scientific Corporation